Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of martrilysin in human gastric cancer

Carcinogenesis

Volumn 25, Issue 3, 2004, Pages 325-332

  Yamamoto, Hiroyuki ^a   Horiuchi, Shina ^a   Adachi, Yasushi ^a   Taniguchi, Hiroaki ^a   Nosho, Katsuhiko ^a   Min, Yongfen ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E1AF; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STOMACH CANCER; TUMOR GROWTH;

ADENOVIRUS E1A PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 7; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 1542504568     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh011     Document Type: Article

References (38)

1. Stetler-Stevenson,W.G. (2001) The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg. Oncol. Clin. N. Am., 10, 383-392.
2. Stetler-Stevenson,W.G. and Yu,A.E. (2001) Proteases in invasion: Matrix metalloproteinases. Semin. Cancer Biol., 11, 143-152.
3. Murray,G.I., Duncan,M.E., Arbuckle,E., Melvin,W.T. and Fothergill,J.E. (1998) Matrix metalloproteinases and their inhibitors in gastric cancer. Gut, 43, 791-797.
4. Yamamoto,H., Itoh,F., Adachi,Y., Sakamoto,H., Adachi,M., Hinoda,Y. and Imai,K. (1997) Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterolgy, 112, 1271-1277.
5. Yamamoto,H., Itoh,F., Iku,S., Adachi,Y., Fukushima,H., Sasaki,S., Mukaiya,M., Hirata,K. and Imai,K. (2001) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: Clinicopathological and prognostic significance of matrilysin expression. J. Clin. Oncol., 19, 1118-1127.
6. Yoshida,K., Narita,M. and Fujinaga,K. (1989) Binding sites of HeLa cell nuclear proteins on the upstream region of adenovirus type 5 E1A gene. Nucleic Acids Res., 17, 10015-10034.
7. Higashino,F., Yoshida,K., Fujinaga,Y., Kamio,K. and Fujinaga,K. (1993) Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein: A new human member of the ets oncogene family. Nucleic Acids Res., 21, 547-553.
8. Shindoh,M., Higashino,F., Kaya,M. et al. (1996) Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines. Am. J. Pathol., 148, 693-700.
9. Baert,J.L., Monte,D., Musgrove,E.A., Albagli,O., Sutherland,R.L. and de Launoit,Y. (1997) Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells. Int. J. Cancer, 70, 590-597.
10. Taguchi,K., Yoshida,K., Sasaki,F. and Fujinaga,K. (1997) Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines. Jpn. J. Cancer Res., 88, 394-400.
11. Higashino,F., Yoshida,K., Noumi,T., Seiki,M. and Fujinaga,K. (1995) Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene, 10, 1461-1463.
12. Kaya,M., Yoshida,K., Higashino,F., Mitaka,T., Ishii,S. and Fujinaga,K. (1996) A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene, 12, 221-227.
13. Hida,K., Shindoh,M., Yasuda,M., Hanzawa,M., Funaoka,K., Kohgo,T., Amemiya,A., Totsuka,Y., Yoshida,K. and Fujinaga,K. (1997) Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities. Am. J. Pathol., 150, 2125-2132.
14. Hanzawa,M., Shindoh,M., Higashino,F. et al. (2001) Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis, 21, 1079-1085.
15. Nishikawa,A., Iwasaki,M., Akutagawa,N., Manase,K., Yamashita,S., Endo,T. and Kudo,R. (2000) Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: Correlation to invasive potential. Gynecol. Oncol., 79, 256-263.
16. Hida,K., Shindoh,M., Yoshida,K., Kudoh,A., Furaoka,K., Kohgo,T., Fujinaga,K. and Totsuka,Y. (1997) Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma. Oral Oncol., 33, 426-430.
17. Benz,C.C., O'Hagan,R.C., Richter,B. et al. (1997) HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene, 15, 1513-1525.
18. Hiroumi,H., Akita-Dosaka,H., Yoshida,K., Shindoh,M., Ohbuchi,T., Fujinaga,K. and Nishimura,M. (2001) Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion. Int. J. Cancer, 93, 786-791.
19. Ozaki,I., Mizuta,T., Zhao,G., Yotsumoto,H., Hara,T., Kajihara,S., Hisatomi,A., Sakai,T. and Yamamoto,K. (2000) Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res., 60, 6519-6525.
20. Horiuchi,S., Yamamoto,H., Min,Y., Adachi,Y., Itoh,F. and Imai,K. (2003) Association of Ets-related transcriptional factor E1AF expression with tumor progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J. Pathol., 200, 568-576.
21. Nomura,H., Fujimoto,N., Seiki,M., Mai,M. and Okada,Y. (1996) Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (Gelatinase A) in human gastric carcinomas. Int. J. Cancer, 69, 9-16.
22. Adachi,Y., Itoh,F., Yamamoto,H. et al. (1998) Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. Int. J. Oncol., 13, 1031-1035.
23. Senota,A., Itoh,F., Yamamoto,H., Adachi,Y., Hinoda,Y. and Imai,K. (1998) Relation of matrilysin messager RNA expression with invasive activity in human gastric cancer. Clin. Exp. Metastasis, 16, 313-321.
24. Liu,X.P., Kawauchi,S., Oga,A., Tsushimi,K., Tsushimi,M., Furuya,T. and Sasaki,K. (2002) Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma. Jpn. J. Cancer Res., 93, 291-295.
25. Fukushima,H., Yamamoto,H., Itoh,F., Nakamura,H., Min,Y., Horiuchi,S., Iku,S., Sasaki,S. and Imai,K. (2001) Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas. Carcinogenesis, 22, 1049-1052.
26. Yamamoto,H., Itoh,F., Hinoda,Y. and Imai,K. (1995) Suppression of matrilysin inhibits colon cancer cell invasion in vitro. Int. J. Cancer, 61, 218-222.
27. Watanabe,H., Nakanishi,I., Yamashita,K., Hayakawa,T. and Okada,Y. (1993) Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: Correlation with cellular invasion. J. Cell Sci., 104, 991-999.
28. Gaire,M., Magbanua,Z., McDonnell,S., McNeil,L., Lovett,D.H. and Matrisian,L.M. (1994) Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J. Biol. Chem., 269, 2032-2040.
29. Crawford,H.C., Fingleton,B.M., Rudolph-Owen,L.A., Goss,K.J., Rubinfeld,B., Polakis,P. and Matrisian,L.M. (1999) The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene, 18, 2883-2891.
30. Brabletz,T., Jung,A., Dag,S. and Kirchner,T. (1999) β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol., 155, 1033-1038.
31. Ougolkov,A.V., Yamashita,K., Mai,M. and Minamoto,T. (2002) Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology, 122, 60-71.
32. Woo,D.K., Kim,H.S., Lee,H.S., Kang,Y.H., Yang,H.K. and Kim,W.H. (2001) Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int. J. Cancer, 95, 108-113.
33. Grabsch,H., Takeno,S., Noguchi,T., Hommel,G., Gabbert,H.E. and Mueller,W. (2001) Different patterns of beta-catenin expression in gastric carcinomas: Relationship with clinicopathological parameters and prognostic outcome. Histopathology, 39, 141-149.
34. Clements,W.M., Wang,J., Sarnaik,A., Kim,O.J., MacDonald,J., Fenoglio-Preiser,C., Groden,J. and Lowy,A.M. (2002) Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res., 62, 3503-3506.
35. Crawford,H.C., Fingleton,B., Gustavson,M.D., Kurpios,N., Wagenaar,R.A., Hassell,J.A. and Matrisian,L.M. (2001) The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol. Cell. Biol., 21, 1370-1383.
36. Nakayama,T., Ito,M., Ohtsuru,A., Naito,S., Nakashima,M., Fagin,J.A., Yamashita,S. and Sekine,I. (1996) Expression of the Ets-1 protoconcogene in human gastric carcinoma Am. J. Pathol., 149, 1931-1939.
37. Westermarck,J., Seth,A. and Kahari,V.M. (1997) Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene, 14, 2651-2660.
38. Howe,L.R., Crawford,H.C., Subbaramaiah,K., Hassell,J.A., Dannenberg,A.J. and Brown,A.M. (2001) PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J. Biol. Chem., 276, 20108-20115.